In our debut podcast for The Cannabinoid Journal we review our first four blog posts with commentary from the authors, examining the state of clinical evidence within the medicinal cannabis industry.
We explore the value of real world data and how this might fit into contemporary evidence-based practice, we discuss the upcoming disease targets and promising clinical studies, and also chat about the frontier discoveries around cannabinoid pharmacology which might impact clinical practice in the future.
In our podcast you will hear from:
Dr Daniel Couch, Medical Lead at the Centre for Medicinal Cannabis
Dr Rosemary Mazanet, Chief Scientific Officer at Columbia Care
Dr Simon Erridge, Business Development Director at Sapphire Medical Clinics and Academic Clinician at Imperial College London
Dr Karen Wright, Senior Lecturer at Lancaster University
Episode 1: The Clinical Evidence for the use of Cannabinoids